Center3 had significantly more patients with < 1% PDL-1 positive tumor cells, 62 patients (83%), in contrast to the 50 (24%) and 28 (20%) patients observed in Center1 and Center2, respectively. The gene discussed is CD274; the disease is neoplasm.